🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT07775495
Starting soon Observational

Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure

NCT07775495 · tracked via the Priya Life Science USA tracker
Sponsor
Ecotera Health LLC
Phase
Observational
Started
2026-08-21
Last updated
2026-08-20

Condition(s) studied

Healthy Adult Participants

Study summary

The goal of this observational study is to evaluate the feasibility and usability of at-home urine sample collection, preparation, and smartphone imaging using the EcoExposure™ platform in adults. The main questions it aims to answer are:

Can participants successfully collect, prepare, and photograph urine samples at home and upload the images using a smartphone app? How consistent is image quality and participant adherence across repeated sampling over approximately 12 weeks? What is the short-term day-to-day variability in optical signals during an intensive daily sampling period?

Participants will:

Complete electronic consent and a brief intake questionnaire Collect and prepare urine samples at home at scheduled timepoints Capture guided smartphone photographs of the prepared samples Upload the images and provide brief feedback through the TrialKit app Optionally add a small reference solution (spike sample) to one sample for technical evaluation only

The study is fully remote and lasts approximately 12 weeks. It is intended for product development and workflow validation purposes only and does not involve any diagnostic or clinical decision-making.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Adults aged 18 years or older * Able to provide electronic informed consent * Willing and able to collect and prepare urine samples at home according to study instructions * Own a smartphone capable of running the TrialKit application and capturing photographs * Willing to complete the required study visits over approximately 12 weeks Exclusion Criteria: * Unable or unwilling to perform the study procedures (urine collection, sample preparation, smartphone imaging, and data upload) * Any condition or circumstance that, in the judgment of the investigator, would prevent the participant from successfully completing the study protocol

Primary outcome measure(s)

Trial sites (51)

FacilityCityRegionStatus
Decentralized / At-Home Participation (U.S.) Birmingham Alabama
Decentralized / At-Home Participation (U.S.) Anchorage Alaska
Decentralized / At-Home Participation (U.S.) Phoenix Arizona
Decentralized / At-Home Participation (U.S.) Little Rock Arkansas
Decentralized / At-Home Participation (U.S.) San Francisco California
Decentralized / At-Home Participation (U.S.) Denver Colorado
Decentralized / At-Home Participation (U.S.) Hartford Connecticut
Decentralized / At-Home Participation (U.S.) Dover Delaware
Decentralized / At-Home Participation (U.S.) Washington D.C. District of Columbia
Decentralized / At-Home Participation (U.S.) Miami Florida
Decentralized / At-Home Participation (U.S.) Atlanta Georgia
Decentralized / At-Home Participation (U.S.) Honolulu Hawaii
Decentralized / At-Home Participation (U.S.) Boise Idaho
Decentralized / At-Home Participation (U.S.) Chicago Illinois
Decentralized / At-Home Participation (U.S.) Indianapolis Indiana
Decentralized / At-Home Participation (U.S.) Des Moines Iowa
Decentralized / At-Home Participation (U.S.) Kansas City Kansas
Decentralized / At-Home Participation (U.S.) Louisville Kentucky
Decentralized / At-Home Participation (U.S.) New Orleans Louisiana
Decentralized / At-Home Participation (U.S.) Augusta Maine
Decentralized / At-Home Participation (U.S.) Baltimore Maryland
Decentralized / At-Home Participation (U.S.) Boston Massachusetts
Decentralized / At-Home Participation (U.S.) Detroit Michigan
Decentralized / At-Home Participation (U.S.) Minneapolis Minnesota
Decentralized / At-Home Participation (U.S.) Jackson Mississippi
Decentralized / At-Home Participation (U.S.) St Louis Missouri
Decentralized / At-Home Participation (U.S.) Billings Montana
Decentralized / At-Home Participation (U.S.) Omaha Nebraska
Decentralized / At-Home Participation (U.S.) Las Vegas Nevada
Decentralized / At-Home Participation (U.S.) Manchester New Hampshire
Decentralized / At-Home Participation (U.S.) Newark New Jersey
Decentralized / At-Home Participation (U.S.) Albuquerque New Mexico
Decentralized / At-Home Participation (U.S.) New York New York
Decentralized / At-Home Participation (U.S.) Charlotte North Carolina
Decentralized / At-Home Participation (U.S.) Fargo North Dakota
Decentralized / At-Home Participation (U.S.) Cincinnati Ohio
Decentralized / At-Home Participation (U.S.) Oklahoma City Oklahoma
Decentralized / At-Home Participation (U.S.) Portland Oregon
Decentralized / At-Home Participation (U.S.) Philadelphia Pennsylvania
Decentralized / At-Home Participation (U.S.) Providence Rhode Island

+ 11 more sites — see the full list on the official registry below.

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07775495 on ClinicalTrials.gov ↗ ← All trials in the USA